Accumulation of radiolabelled platelets and fibrin on the carotid artery of rabbits after angioplasty: Effects of heparin and dipyridamole

Thrombosis and Haemostasis

Volumn 90, Issue 6, 2003, Pages 1179-1186

  Van Ryn, Joanne ^a   Lorenz, Martin ^b   Merk, Herbert ^a   Buchanan, Michael R ^c   Eisert, Wolfgang G ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^b All for One Software AG   (Germany)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Animal models; Dipyridamole; Fibrin; Platelet pharmacology; Vascular injury

Indexed keywords

ALTEPLASE; DIPYRIDAMOLE; FIBRIN; FIBRIN ANTIBODY; FIBRINOGEN; HEPARIN; IODINE 123; KETAMINE; PROSTACYCLIN; TECHNETIUM 99M; TISSUE PLASMINOGEN ACTIVATOR; XYLAZINE;

ANGIOPLASTY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL WALL; BOLUS INJECTION; CAROTID ARTERY; CAROTID ARTERY INJURY; CONTROLLED STUDY; DRUG EFFECT; DRUG HALF LIFE; DRUG INFUSION; ELECTRON MICROSCOPY; IN VIVO STUDY; ISOTOPE LABELING; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; RABBIT; THROMBOCYTE; THROMBOGENESIS; THROMBOSIS;

EID: 0346903192     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/th03-05-0305     Document Type: Article

References (34)

1. Popma JJ, Ohman EM, Weitz J, et al. Antithrombotic therapy in patients undergoing percutaneous coronary intervention. Chest 2001; 119: 321S-36S.
2. Narins CR, Hillegass WB, Nelson CL, et al. Relation between activated clotting time during angioplasty and abrupt closure. Circulation 1996; 93 667-71.
3. Gerns GAA, Stewart-Lee AL, Änggård EE. Arterial response to mechanical injury: Balloon catheter de-endothelialization. Atherosclerosis 1992; 92: 89-104.
4. Virmani R, Farb A, Burke AP. Coronary angioplasty from the perspective of atherosclerotic plaque: Morphologic predictors of immediate success and restenosis. Am Heart J 1994; 127: 163-79.
5. Mintz GS, Pichard AD, Kent KM, et al.. Axial plaque redistribution as a mechanism of percutaneous transluminal coronary angioplasty. Amer J Cardiol 1996; 77: 427-30.
6. De Feyter PJ, Van Den Brand M, Jaarman GJ, et al. Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty. Circulation 1991; 83: 927-36.
7. Plante S, Larman GJ, De Feyter P, et al. Acute complications of percutaneous transluminal coronary angioplasty for total occlusion. Am Heart J 1991; 121: 417-26.
8. Hirsh J, Anand SS, Halperin JL, et al. Guide to anticoagulant therapy: Heparin: A statement for healthcare professionals from the American Heart Association. Circulation 2001; 103: 2994-3018.
9. Gargan PE, Gaffney PJ, Pleasants JR, et al. A monoclonal antibody which recognises an epitopic region unique to the intact fibrin polymeric structure. Fibrinolysis 1993; 7: 275-83.
10. Regoeczi E. Fibrinogen catabolism: Kinetics of catabolism following sudden elevation of the pool with exogenous fibrinogen. Clin Sci 1970; 38: 111-21.
11. Greenwood FC, Hunter WM, Glovers JS. The preparation of 131I-labelled human growth hormone of high specific radioactivity. Biochem J 1963; 89: 114-21.
12. Becker W, Borst U, Krahe T, et al. Tc-99m-HMPAO labelled human platelets: In vitro and in vivo results. Eur J Nucl Med 1989; 15: 296-301.
13. Lorenz M, Van Ryn J, Merk H, et al. Portable gamma spectroscopy system for simultaneously monitoring radiotracers in vivo using CdTe and CdZnTe radiation detector probes. Nucl Instr and Meth in Phys Res 1994; A353: 448-52.
14. Proctor RR, Rappaport SI. The partial thromboplastin time with kaolin. Am J Clin Pathol 1961; 36: 212-18.
15. Bruning JL, Kintz BL. Computational Handbook of Statistics. Glenview, IL: Scott, Foresman and Company; 1977.
16. Steele PM, Chesebro JH, Stanson AW, et al. Balloon Angioplasty. Natural history of the pathophysiological response to injury in a pig model. Circ Res 1985; 57: 105-112.
17. Groves HM, Kinlough-Rathbone RL, Richardson M, et al. Platelet interaction with damaged rabbit aorta. Lab Invest 1979; 40: 194-200.
18. Kelly AB, Marzec UM, Krupski W, et al. Hirudin interruption of heparin-resistant arterial thrombus formation in baboons. Blood 1991; 77: 1006-12.
19. Heras M, Chesebro JH, Penny WJ, et al. Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Circulation 1989; 79: 657-65.
20. Harker LA, Kelly AB, Hanson SR. Experimental arterial thrombosis in nonhuman primates. Circulation 1991; 83(suppl IV): IV41-IV55.
21. Richardson M, Hatton MWC, Buchanan MR, et al. Wound healing in the media of the normolipemic rabbit carotid artery injured by air drying or by balloon catheter de-endothelialization. Am J Pathol 1990; 137: 1453-65.
22. 2 (prostacyclin) by cultured human and bovine endothelial cells. Proc Natl Acad Sci USA 1997; 74: 3922-6.
23. McAdam BF, Catella-Lawson F, Mardini IA, et al. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2. Proc Natl Acad Sci USA 1999; 96: 272-7.
24. Ofosu FA, Sie P, Modi G, et al. The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin. Biochem J 1987; 243: 579-88.
25. Hatton MWC, Moar SL, Richardson M. Enhanced binding of fibrinogen by the subendothelium after treatment of the rabbit aorta with thrombin. J Lab Clin Med 1990; 115: 356-64.
26. Patrono C, Coller B, Dallen JE, et al.. Platelet-active drugs. Relationship among dose, effectiveness and side effeects. Chest 2001; 119: 39S-63S.
27. Eisert WG. Dipyridamole. In: Platelets. A Michelson, ed. Academic Press, San Diego, 2002. In Press.
28. Diener HC, Cuhna L, Forbes C, et al. European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996; 143: 1-13.
29. Ahn HS, Crim W, Romano M, et al. Effects of selective inhibitors on cyclic nucleotide phosphodiesterase of rabbit aorta. Biochem Pharmacol 1989; 38: 3331-9.
30. Gillespie PG, Beavo JA. Inhibition and stimulation of photoreceptor phosphodiesterases by dipyridamole and M&B 22,948. Mol Pharmacol 1989; 36: 773-81.
31. Buchanan MR, Hirsh J. A comparison of the effects of aspirin and dipyridamole on platelet aggregation in vivo and ex vivo. Thromb Res 1978; 13: 517-29.
32. Gresele P, Zojy C, Deckmyn H, et al. Dipyridamole inhibits platelet aggregation in whole blood. Thromb Haemost 1983; 50: 852-6.
33. Neri Serneri GG, Masotti G, Poggesi L, et al. Enhanced prostacyclin production by dipyridamole in man. Eur J Clin Pharmacol 1981; 21: 9-15.
34. Weber E, Haas TA, Muller TH, et al. Relationship between vessel wall 13-HODE synthesis and vessel wall thrombogenicity following injury: Influence of salicylate and dipyridamole treatment. Thromb Res 1990; 57: 383-92.